Some psychedelic medicine developers want to ditch the therapy aspect. What could go wrong?
22 min
News and insights read out for you.
10,000+ audio articles. 30+ world-leading publications.
All in 1 subscription.
10,000+ audio articles. 30+ world-leading publications.
All in 1 subscription.
The case for MDMA’s approval is riddled with problems
10 mins | Jun 12, 2024
The FDA is considering approving MDMA alongside psychotherapy as a treatment for PTSD. But evidence of the drug’s effectiveness isn’t clear cut. Emily Mullin investigates the trial data and potential biases surrounding the case. Read by Emily Woo Zeller.
